Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Nature Genetics|February 10, 2015
A Big Bang model of human colorectal tumor growthAndrea Sottoriva, Haeyoun Kang, Zhicheng Ma, et al.Biorxiv : the Preprint Server for Biology|August 20, 2025
RIG-I-dependent tumor-intrinsic type I interferon signaling restricts growth in breast cancer 3D cultureKatherine Liu, Lise Mangiante, Roni Levin-Konigsberg, et al.Molecular Carcinogenesis|June 20, 2012
Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese populationZhicheng Ma, Qingfeng Hu, Zhuo Chen, et al.Human Molecular Genetics|August 17, 2010
Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cellsJo-Ling Liao, Juehua Yu, Kevin Huang, et al.Nature Genetics|June 19, 2019
Quantitative evidence for early metastatic seeding in colorectal cancerZheng Hu, Jie Ding, Zhicheng Ma, et al.Nature Cancer|December 30, 2021
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts responseKatherine L McNamara, Jennifer L Caswell-Jin, Rohan Joshi, et al.Histopathology|December 28, 2025
Genetic and immunohistochemical studies identify recurrent ACTB mutations and PTEN alterations in tubular adenomas of the breastHnin Ingyin, James P Solomon, Yuewei Li, et al.Nature|May 31, 2023
Deterministic evolution and stringent selection during preneoplasiaKasper Karlsson, Moritz J Przybilla, Eran Kotler, et al.Nature Communications|June 1, 2019
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapyJennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter, et al.Nature Communications|February 10, 2019
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapyJennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter, et al.Pageof 4